Table 2 Disease activity during 12-Month follow-up, according to therapeutic decision-making based on each extra-musculoskeletal manifestation
Variable | Baseline | 3Â months | 6Â months | 12Â months | p |
|---|---|---|---|---|---|
Active rAAU, n (%) | 48 (100%) | 11 (22.9%) | 10 (20.8%) | 7 (14.6%) |  < 0.001 |
Active Psoriasis N (%) | 78 (100%) | 55 (70.5%) | 48 (57.7%) | 40 (51.3%) |  < 0.001 |
PASI | 11.1 (10.5) | 6.9 (8.2) | 7.8 (11.6) | 3.4 (5.6) |  < 0.001 |
Active ibd, N (%) | 78 (100%) | 55 (70.5%) | 48 (57.7%) | 40 (51.3%) |  < 0.0001 |
Diarrhea episodesmean/day | 5.2 (3.0) | 3.3 (4.1) | 1.6 (3.0) | 1.5 (3.0) |  < 0.001 |
Blood or mucus in stools, n (%) | 6 (40%) | 6 (40%) | 3 (20%) | 2 (13.3%) | 0.08 |
Abdominal Pain, n (%) | 6 (40%) | 6 (40%) | 3 (20%) | 2 (13.3%) | 0.003 |